Companies
Hyperbiotics
Pro-Dental chewable tablets using clinically studied strains to lessen plaque build-up across the mouth and digestive tract.
- Country
- United States
Commercial
Pro-Dental chewable tablets; clinically studied strains targeting oral + digestive tract; reduces plaque build-up
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $6 million investment by Probi in Vital Nutrients Holdings, 2020 | nutritioninsight.com · probi.com |
| Production site | Manufacturing facility in Middletown, Connecticut, USA | miadb.com · vitalnutrients.co |
| Certification | NSF-certified, cGMP compliant facility | amazon.com · vitalnutrients.co |
| Headcount | Approximately 50 employees (as of 2019/2020 for Vital Nutrients Holdings) | nutritioninsight.com · probi.com |
| Revenue | Approximately $40 million (as of 2019 for Vital Nutrients Holdings) | nutritioninsight.com · probi.com |
Independent sources: amazon.com · miadb.com · nutritioninsight.com · probi.com · vitalnutrients.co
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Probiotic oral care | specialty-fine-chem | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.